Hexima Ltd (HXL) - Total Liabilities
Based on the latest financial reports, Hexima Ltd (HXL) has total liabilities worth AU$40.70K AUD (≈ $28.80K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Hexima Ltd generate cash to assess how effectively this company generates cash.
Hexima Ltd - Total Liabilities Trend (2005–2024)
This chart illustrates how Hexima Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Hexima Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Hexima Ltd Competitors by Total Liabilities
The table below lists competitors of Hexima Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hynion AS
OL:HYN
|
Norway | Nkr29.09 Million |
|
CMC Metals Ltd
V:CMB
|
Canada | CA$774.52K |
|
Mercia Technologies PLC
LSE:MERC
|
UK | GBX15.58 Million |
|
Ramsdens Holdings PLC
LSE:RFX
|
UK | GBX28.20 Million |
|
Pineapple Financial Inc.
NYSE:PAPL
|
USA | $3.86 Million |
|
Genprex Inc
NASDAQ:GNPX
|
USA | $2.79 Million |
|
CryptoStar Corp
V:CSTR
|
Canada | CA$3.03 Million |
Liability Composition Analysis (2005–2024)
This chart breaks down Hexima Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hexima Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 38.26 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 37.73 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hexima Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hexima Ltd (2005–2024)
The table below shows the annual total liabilities of Hexima Ltd from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | AU$40.70K ≈ $28.80K |
-83.63% |
| 2023-12-31 | AU$248.67K ≈ $175.95K |
+42.55% |
| 2022-12-31 | AU$174.45K ≈ $123.43K |
-97.18% |
| 2021-12-31 | AU$6.19 Million ≈ $4.38 Million |
+11.90% |
| 2020-12-31 | AU$5.53 Million ≈ $3.91 Million |
+63.16% |
| 2019-12-31 | AU$3.39 Million ≈ $2.40 Million |
-13.82% |
| 2018-12-31 | AU$3.93 Million ≈ $2.78 Million |
+94.59% |
| 2017-12-31 | AU$2.02 Million ≈ $1.43 Million |
+8.12% |
| 2016-12-31 | AU$1.87 Million ≈ $1.32 Million |
-7.14% |
| 2015-12-31 | AU$2.01 Million ≈ $1.42 Million |
+10.66% |
| 2014-12-31 | AU$1.82 Million ≈ $1.29 Million |
-8.10% |
| 2013-12-31 | AU$1.98 Million ≈ $1.40 Million |
+30.82% |
| 2012-12-31 | AU$1.51 Million ≈ $1.07 Million |
-42.49% |
| 2009-12-31 | AU$2.63 Million ≈ $1.86 Million |
+1.95% |
| 2008-12-31 | AU$2.58 Million ≈ $1.83 Million |
-11.50% |
| 2007-12-31 | AU$2.92 Million ≈ $2.06 Million |
-80.75% |
| 2006-12-31 | AU$15.15 Million ≈ $10.72 Million |
+335.74% |
| 2005-12-31 | AU$3.48 Million ≈ $2.46 Million |
-- |
About Hexima Ltd
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of plant-derived proteins for applications as human therapeutics. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.